Q2 2026 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsAnunay Shahi - Head of Investor RelationsSumant Sinha ...
With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback